Status: current, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4824341000168119 | amivantamab (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4824351000168117 | amivantamab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| amivantamab | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has intended active ingredient | True | amivantamab | Inferred relationship | Some | 613977832 |
| Rybrevant 350 mg/7 mL injection, 7 mL vial | has Australian BoSS | True | amivantamab | Inferred relationship | Some | 613977832 |
| amivantamab | has intended active ingredient | True | amivantamab | Inferred relationship | Some | 557936323 |
| amivantamab 350 mg/7 mL injection, vial | has Australian BoSS | True | amivantamab | Inferred relationship | Some | 1462800394 |
| amivantamab 350 mg/7 mL injection, vial | has intended active ingredient | True | amivantamab | Inferred relationship | Some | 1462800394 |
This concept is not in any reference sets
FHIR